Invitae is making strides in genomics, focusing on growth catalysts in various clinical areas. With a strong cash balance of $389M and ongoing cash burn reduction, Invitae is in a robust financial position. As we approach the upcoming ER, a short squeeze could be on the horizon. Stay tuned! #NVTA #EarningsReport

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2022 Update

https://seekingalpha.com/article/4572886-tracking-cathie-woods-ark-invest-13f-portfolio-q4-2022-update?source=feed

#JohnVincent #SHOP:CA #DKNGZ #ACCD #ACHR #ADPT #ARCT #BEAM #BLDE #CDNA #CDXS #CERS #CGEN #COIN #CRSP #DKNG #EXAS #FATE #GBTC #HOOD #INCY #IONS #IRDM #KIND #KTOS #MASS #MELI #MKFG #NNDM #NTLA #NVDA #NVTA #PACB #PATH #PSNL #RBLX #ROKU #RPTX #SDGR #SHOP #SURF #TDOC #TRMB #TSLA #TWLO #TWOU #TWST #VCYT #VERV #VUZI